UTUC | Upper tract urothelial carcinoma |
UBC | Urinary bladder urothelial carcinoma |
PD-L1 | Programmed Death Ligand 1 |
PD-1 | Programmed Death 1 |
EV | Enfortumab vedotin |
MMAE | Monomethyl auristatin E |
TMA | Tissue microarray |
EDTA | Tris-ethylenediaminetetraacetic acid |
H-score | Histochemical scoring system |
PI3K | Phosphoinositide 3-kinase |
AKT | Protein kinase B |
FDA | Food and Drug Administration |
HR | Hazard ratio |
CI | Confidence interval |
MI | Muscle-invasive |
NMI | Non-muscle-invasive |
Inf | Infinity |